Non-Invasive Remote Patient Monitoring Guidance Updated For Post-Pandemic World

An updated US FDA guidance document on changing the indications for use of non-invasive devices from in-clinic to at-home doesn’t change much post PHE.

• Source: Shutterstock

A guidance on the changes appropriate for remote patient monitoring devices being used in homes was revised to reflect the end of the COVID-19 public health emergency, but not much has changed.

The Food and Drug Administration’s enforcement policy for non-invasive remote monitoring devices used to support patient monitoring guidance document...

More from Guidance

More from Compliance